These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16443530)

  • 1. Implantable cardioverter-defibrillators are still getting smarter: now a way to identify lead failure and prevent resultant inappropriate shocks.
    Epstein AE
    Heart Rhythm; 2006 Feb; 3(2):163-4. PubMed ID: 16443530
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Gillberg JM; Wood MA; Vijayaraman P; Shepard RK; Ellenbogen KA
    Heart Rhythm; 2006 Feb; 3(2):155-62. PubMed ID: 16443529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent inappropriate shocks from an implantable cardioverter defibrillator:
    Moore DR; Kok LC; Vijayaraman P
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):116-7. PubMed ID: 15028086
    [No Abstract]   [Full Text] [Related]  

  • 4. Inappropriate implantable cardioverter-defibrillator therapy during exercise: what is the mechanism?
    Vollmann D; Lüthje L; Zabel M
    Heart Rhythm; 2009 May; 6(5):718-9. PubMed ID: 19303370
    [No Abstract]   [Full Text] [Related]  

  • 5. An algorithm to predict implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Patel AS; Bounds CA; Shepard RK; Wood MA; Ellenbogen KA
    J Am Coll Cardiol; 2004 Nov; 44(9):1898-902. PubMed ID: 15519026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate shocks in a patient treated with a cardioverter defibrillator.
    Hutse W; Tavernier R; Jordaens L
    Heart; 1997 Apr; 77(4):386-7. PubMed ID: 9155627
    [No Abstract]   [Full Text] [Related]  

  • 7. Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator.
    Adler A; Rosso R; Meir I; Viskin S
    Europace; 2013 Mar; 15(3):362-5. PubMed ID: 23118003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programming implantable cardioverter-defibrillators in primary prevention: higher or later.
    Clementy N; Pierre B; Simeon E; Lallemand B; Fauchier L; Babuty D
    Arch Cardiovasc Dis; 2014 May; 107(5):308-18. PubMed ID: 24834904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A covariance-based algorithm: a novel technique for rhythm discrimination in ICDs.
    Kamousi B; Lin B; Al-Ahmad A; Hsia H; Zei P; Natale A; Moss A; Daubert J; Zareba W; Wang P
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():5478-81. PubMed ID: 19163957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An electrical storm with more than 3000 shocks in a patient with an implantable cardioverter-defibrillator: is jet-lag a trigger?
    Han SW; Kim YN; Lee YS; Hyun DW; Kim D; Hur SH; Kim KS; Kim KB
    Int J Cardiol; 2005 Sep; 104(2):235-7. PubMed ID: 16168822
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of flecainide therapy on inappropriate shocks and arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
    Jacquemart C; Ould Abderrahmane F; Massin MM
    J Electrocardiol; 2012; 45(6):736-8. PubMed ID: 22672791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.
    Gold MR; Weiss R; Theuns DA; Smith W; Leon A; Knight BP; Carter N; Husby M; Burke MC
    Heart Rhythm; 2014 Aug; 11(8):1352-8. PubMed ID: 24732366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 16. Implantable cardioverter defribrillator shocks: a troubleshooting guide.
    Swerdlow CD; Zhang J
    Rev Cardiovasc Med; 2001; 2(2):61-72. PubMed ID: 12439383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of ventricular tachycardia degeneration by low-energy implantable cardioverter-defibrillator shocks: a case report.
    Cagli KE; Guray U; Akpinar I; Sen N; Aras D; Topaloglu S
    J Electrocardiol; 2010; 43(1):68-70. PubMed ID: 19446839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefit of a second burst antitachycardia sequence for fast ventricular tachycardia in patients with implantable cardioverter defibrillators.
    Anguera I; Dallaglio P; Sabaté X; Nuñez E; Gracida M; Di Marco A; Sugrañes G; Cequier A
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):486-94. PubMed ID: 24215374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular arrhythmias in patients with implanted cardioverter defibrillators.
    John RM; Stevenson WG
    Trends Cardiovasc Med; 2012 Oct; 22(7):169-73. PubMed ID: 22902094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICD arrhythmia detection and discrimination: are we there yet?
    Kenigsberg DN; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1320-2. PubMed ID: 17081200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.